Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
TLR7 agonist
c-MET, Tie-2, VEGFR inhibitor.
D2/3 antagonist, hERG K+ channel blocker.
Inhibitor of CDK.
Flavanol originally found in Camilla (green tea...
Vitamin E component
Flavonol glycoside originally found in Epimediu...
Flavonoid found in various plant sources; GABA-...
Indoleamine-2,3-dioxygenase inhibitor.
PKC and PKG inhibitor.
NSAID; COX-1/2 and lipoxygenase inhibitor.
5-HT3 antagonist.
β-lactam carbapenem; penicillin binding protei...
PKC activator, carcinogen.
Triazole; gibberellin inhibitor, potential 14-Î...
VEGFR1/2/3, TIE2, PDGFRβ, FGFR1, c-Kit, RET, B...
Neuroactive mycotoxin produced by Penicillum an...
Endogenous steroid hormone; ERβ, NMDA, σ1 ago...
Enone.
β-lactamase inhibitor.